SDZ-201106 is a diphenylpiperazinylindole derivative acting as a positive inotropic agent by modulating voltage-gated sodium channels to increase cardiac contractility. Primarily utilized in cardiovascular… Read more









SDZ-201106 is a diphenylpiperazinylindole derivative acting as a positive inotropic agent by modulating voltage-gated sodium channels to increase cardiac contractility. Primarily utilized in cardiovascular research, this compound supports investigations into mechanisms for restoring myofibrillar calcium sensitivity and developing novel therapeutic interventions. Analytical laboratories require precise reference standards to ensure rigorous quality control and accurate research outcomes. This category includes essential analytical tools such as SDZ-201106 impurities, chiral enantiomers, and stable isotope labelled compounds. These materials are critical for impurity profiling, method validation, and conducting pharmacokinetic studies where precise identification and quantification are required. By providing access to high-quality related substances, including the (R) and (S) enantiomers and deuterium-labelled variants, these products facilitate reliable data generation in complex analytical workflows and experimental settings.